Aspirin (Acetylsalicylic acid, BAYE4465)

DRUG4 trials

Sponsors

Bayer

Conditions

Colorectal NeoplasmsCommon ColdModerate Risk of CVDPharmacology, Clinical

Phase 1

To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults.

CompletedNCT02394093

BayerPharmacology, Clinical

Start: 2015-02-28End: 2015-03-31Updated: 2016-09-19

Phase 3

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

CompletedNCT00501059

BayerModerate Risk of CVD

Start: 2007-07-05End: 2016-11-15Updated: 2018-10-26

Phase 4

Symptomatic Treatment of Common Cold Symptoms

CompletedNCT01033526

BayerCommon Cold

Start: 2005-10-31End: 2007-06-30Updated: 2009-12-16

Unknown Phase

EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan

CompletedNCT03579732

BayerColorectal Neoplasms

Start: 2018-06-29End: 2019-09-30Updated: 2020-09-29

Related Papers

Design and rationale for the ASSOS study: Appropriateness of aspirin use in medical outpatients a multicenter and observational study.

2018-12-012 citations

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.

2018-08-26545 citations